10-95686506-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015631.6(TCTN3):c.877C>T(p.Gln293*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,613,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_015631.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCTN3 | NM_015631.6 | c.877C>T | p.Gln293* | stop_gained | 7/14 | ENST00000371217.10 | NP_056446.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCTN3 | ENST00000371217.10 | c.877C>T | p.Gln293* | stop_gained | 7/14 | 1 | NM_015631.6 | ENSP00000360261.5 | ||
TCTN3 | ENST00000265993.13 | c.931C>T | p.Gln311* | stop_gained | 7/14 | 1 | ENSP00000265993.9 | |||
TCTN3 | ENST00000430368.6 | c.640C>T | p.Gln214* | stop_gained | 5/10 | 2 | ENSP00000387567.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251270Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135806
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461776Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727202
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74306
ClinVar
Submissions by phenotype
Orofacial-digital syndrome IV Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 22, 2014 | The Gln293X variant in TCTN3 has not been previously reported in individuals with disease or in large population studies. This nonsense variant leads to a premature termination codon at position 293, which is predicted to lead to a truncated or absent protein. Nonsense and other loss-of-function variants in TCTN3 have been associated with autosomal recessive orofaciodigital syndrome type IV (Thomas 2012). In summary, the Gln293X variant meets our criteria to be classified as pathogenic for orofaciodigital syndrome 4 in an recessive manner (http://personalizedmedicine.partners.org/Laboratory-For-Molecular-Medicine). - |
Orofacial-digital syndrome IV;C3553758:Joubert syndrome 18 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2023 | This sequence change creates a premature translational stop signal (p.Gln293*) in the TCTN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TCTN3 are known to be pathogenic (PMID: 2692869, 22883145, 25118024). This variant is present in population databases (rs764091969, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with TCTN3-related conditions. ClinVar contains an entry for this variant (Variation ID: 208618). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at